Tofflon Science and Technology Group Co., Ltd. (SHE:300171)
China · Delayed Price · Currency is CNY 17.81
+0.46 (2.65%)
At close: Jan 23, 2026
SHE:300171 Revenue
Tofflon Science and Technology Group had revenue of 1.28B CNY in the quarter ending September 30, 2025, with 6.39% growth. This brings the company's revenue in the last twelve months to 5.22B, up 8.70% year-over-year. In the year 2024, Tofflon Science and Technology Group had annual revenue of 5.01B, down -11.19%.
Revenue (ttm)
5.22B
Revenue Growth
+8.70%
P/S Ratio
2.59
Revenue / Employee
964.44K
Employees
5,417
Market Cap
13.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.01B | -631.55M | -11.19% |
| Dec 31, 2023 | 5.64B | 172.27M | 3.15% |
| Jan 1, 2023 | 5.47B | 1.28B | 30.46% |
| Jan 1, 2022 | 4.19B | 1.48B | 54.83% |
| Dec 31, 2020 | 2.71B | 443.68M | 19.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Truking Technology | 5.55B |
| Zhende Medical | 4.32B |
| Micro-Tech (Nanjing) Co.,Ltd | 3.12B |
| Shenyang Xingqi Pharmaceutical | 2.41B |
| Autek China | 1.82B |
| Sansure Biotech | 1.67B |
| Andon Health | 1.57B |
| Eyebright Medical Technology (Beijing) | 1.48B |